CoChat

Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Abstract Background and study aims Gastric cancer (GC) is usually preceded by premalignant gastric lesions (GPLs) such as gastric intestinal metaplasia (GIM). Information on risk factors associated with neoplastic progression of GIM are scarce. This study aimed to identify predictors for progression of GIM in areas with low GC incidence. Patients and methods The Progression and Regression of Precancerous Gastric Lesions (PROREGAL) study includes patients with GPL. Patients underwent at least two upper endoscopies with random biopsy sampling. Progression of GIM means an increase in severity according to OLGIM (operative link on gastric intestinal metaplasia) during follow-up (FU). Family history and lifestyle factors were determined through questionnaires. Serum Helicobacter pylori infection, pepsinogens (PG), gastrin-17 and GC-associated single nucleotide polymorphisms (SNPs) were determined. Cox regression was performed for risk analysis and a chi-squared test for analysis of single nucleotide polymorphisms. Results Three hundred and eight patients (median age at inclusion 61 years, interquartile range (IQR: 17; male 48.4 %; median FU 48 months, IQR: 24) were included. During FU, 116 patients (37.7 %) showed progression of IM and six patients (1.9 %) developed high-grade dysplasia or GC. The minor allele (C) on TLR4 (rs11536889) was inversely associated with progression of GIM (OR 0.6; 95 %CI 0.4–1.0). Family history (HR 1.5; 95 %CI 0.9–2.4) and smoking (HR 1.6; 95 %CI 0.9–2.7) showed trends towards progression of GIM. Alcohol use, body mass index, history of H. pylori infection, and serological markers were not associated with progression. Conclusions Family history and smoking appear to be related to an increased risk of GIM progression in low GC incidence countries. TLR4 (rs11536889) showed a significant inverse association, suggesting that genetic information may play a role in GIM progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/a-1314-6626

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flowchart of the included subjects. IC, informed consent; PGL, premalignant gastric lesion; MALT, mucosa-associated lymphoid tissue.
Fig. 1 Flowchart of the included subjects. IC, informed consent; PGL, premalignant gastric lesion; MALT, mucosa-associated lymphoid tissue.CC BY-NC-ND · PubMed Central
Fig. 2 Percentages of progressors per OLGIM stage at baseline and maximal OLGIM stage at the first time point of progression during follow up.
Fig. 2 Percentages of progressors per OLGIM stage at baseline and maximal OLGIM stage at the first time point of progression during follow up.CC BY-NC-ND · PubMed Central
Fig. 3 Analysis of risk factors associated with progression of intestinal metaplasia. BMI, body mass index; CI, confidence interval; Hp, Helicobacter pylori ; HR, hazard ratio.
Fig. 3 Analysis of risk factors associated with progression of intestinal metaplasia. BMI, body mass index; CI, confidence interval; Hp, Helicobacter pylori ; HR, hazard ratio.CC BY-NC-ND · PubMed Central
Fig. 4 Flowchart of available information on family history. Subjects of the PROREGAL cohort with known gastric premalignant lesions and the proportion of subjects with a positive family history. FD, first-degree relative; GC, gastric cancer; IM, intestinal metaplasia; SD, second-degree relative.
Fig. 4 Flowchart of available information on family history. Subjects of the PROREGAL cohort with known gastric premalignant lesions and the proportion of subjects with a positive family history. FD, first-degree relative; GC, gastric cancer; IM, intestinal metaplasia; SD, second-degree relative.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 30

Metadata

Authors
Mommersteeg, M. C., Eikenboom, E. L., Nieuwenburg, S. A. V., Yu, B., den Hollander, W. J., Holster, I. L., den Hoed, C. M., Capelle, L. G., Tang, T. J., Anten, M.-P., Prytz-Berset, I., Witteman, E. M., ter Borg, F., Burger, J. P. W., Bruno, M. J., Fuhler, G. M., Peppelenbosch, M. P., Doukas, M., Kuipers, E. J., & Spaander, M. C. W.
Affiliations
  • Erasmus MC (NL)
  • Leiden University Medical Centre, Leiden, The Netherlands
  • Departments of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
  • Meander Medisch Centrum (NL)
  • IJsselland Ziekenhuis (NL)
  • Sint Franciscus Gasthuis (NL)
  • More and Romsdal Trust Ålesund, Ålesund, Norway
  • Canisius-Wilhelmina Ziekenhuis (NL)
  • Deventer Hospital, Deventer, The Netherlands
  • Rijnstate Hospital (NL)
Venue
Endoscopy International Open
Published
2021-02-18
Volume
09
Issue
03
Pages
E297-E305
ISSN
  • 2196-9736 (ISSN-L)
  • 2364-3722
OpenAlex
W3130942211
Cited by
27
References
46
Citations by year
2026: 3 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 4
FWCI
4.23
Type
journal article
Language
en
Open access
Locations
  • Endoscopy International Open (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
Keywords
gastric intestinal metaplasia, tumor progression, gastric cancer, premalignant gastric lesions, TLR4, family history (medicine), smoking, genetic susceptibility, high-grade dysplasia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.